Cerus (CERS) Stock Price Up 6.2%
Cerus Co. (NASDAQ:CERS)’s share price rose 6.2% on Friday . The company traded as high as $4.63 and last traded at $4.59. Approximately 1,429,141 shares changed hands during mid-day trading, a decline of 10% from the average daily volume of 1,595,042 shares. The stock had previously closed at $4.32.
CERS has been the topic of a number of analyst reports. Robert W. Baird reissued a “buy” rating and issued a $5.00 price target on shares of Cerus in a research note on Friday, December 1st. ValuEngine raised Cerus from a “strong sell” rating to a “sell” rating in a research note on Thursday, January 4th. Cantor Fitzgerald restated a “buy” rating and set a $5.00 price objective on shares of Cerus in a research report on Tuesday, January 23rd. BidaskClub lowered Cerus from a “sell” rating to a “strong sell” rating in a research report on Friday, December 29th. Finally, Zacks Investment Research upgraded Cerus from a “hold” rating to a “buy” rating and set a $4.00 price objective for the company in a research report on Wednesday, November 8th. Three equities research analysts have rated the stock with a sell rating, one has given a hold rating and four have given a buy rating to the stock. Cerus presently has an average rating of “Hold” and an average target price of $5.83.
The company has a debt-to-equity ratio of 0.80, a quick ratio of 3.11 and a current ratio of 3.71.
Cerus Company Profile
Cerus Corporation is a biomedical products company. The Company is engaged in developing and commercializing the INTERCEPT Blood System for blood safety. The Company operates through blood safety segment. The Company’s INTERCEPT Blood System is based on its technology for controlling biological replication, and is designed to reduce blood-borne pathogens in donated blood components intended for transfusion.
Receive News & Ratings for Cerus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerus and related companies with MarketBeat.com's FREE daily email newsletter.